| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8570509 | Heart & Lung: The Journal of Acute and Critical Care | 2017 | 5 Pages |
Abstract
Although anthracycline-induced cardiomyopathy may have a poor prognosis, levosimendan was shown to be effective in this patient. Therefore, levosimendan may represent a possible therapeutic option in such cases.
Keywords
LevosimendanLVSFLVEFTTEIVCInferior vena cava diameterPASPLVEDAnthracyclinesTransthoracic echocardiographyright ventricular fractional area changeTricuspid regurgitationDoxorubicinCardiotoxicitypulmonary artery systolic pressureTAPSEheart failuremitral regurgitationCardiomyopathyleft ventricular ejection fractiontricuspid annular plane systolic excursion
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nikolaos MD, MSc, Stefanos MD, Joseph MD, PhD, Dimitra-Christina MD, Stefania MD, George MD, Helen MD, George MD, PhD, Epaminondas MD, PhD,